Filing Details

Accession Number:
0001140361-15-034400
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-03 17:41:58
Reporting Period:
2015-09-01
Filing Date:
2015-09-03
Accepted Time:
2015-09-03 17:41:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1626854 S Jeremy Caldwell C/O Ardelyx, Inc.
34175 Ardenwood Blvd, Suite 200
Fremont CA 94555
Evp, Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-09-01 643 $18.32 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 12, 2015.
  2. Consists of 643 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2015.